SEARCH

SEARCH BY CITATION

References

  • Chauret, N., A. Gauthier, J. Martin & D. A. Nicoll-Griffth: In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab. Disp. 1997, 25, 11301136.
  • Fujimori, K. A., H. Takahashi, B. S. Numata & A. Takanaka: Drug metabolizing enzyme systems of Göttingen miniature pigs. In: Swine in Biomedical Research 1986, 1, 533548. Ed.: M. E.Tumbleson. Plenum Press, New York.
  • Guengerich, F. P., M. V. Martin, P. H. Beaune, P. Kremers, T. Wolff & J. Waxman: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphisme in oxidative drug metabolism. J. Biol. Chem. 1996, 261, 50515060.
  • Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Maenpaa, J. Edwards, A. R. Boobis & H. Raunio: Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 1996, 51, 403411.
  • Hellmold, H., J. G. Lamb, A. Wyss, J. Å. Gustafsson & M. Wqarner: Developmental and endocrine regulation of P450 isoforms in rat breast. Mol. Pharm. 1995, 48, 630638.
  • Ikeya, K., A. K. Jaiswai, R. A. Owens, J. E. Jones, D. W. Nebert & S. Kimura: Human CYP1A2: Sequence, gene structure, comparison with mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol. Endocrinol. 1989, 3, 13991408.
  • Madden, S., D. Gentile, G. Crawford, A. Simpson & A. Johnston: Cytochrome P450 activities in hepatic microsomes from the minipig. Abstract S3–1 from the 12th ISMDO meeting 1998.
  • Monshouwer, M., R. F. Witkamp, S. M. Nijmeijer, L. A. M. G. Van Leengoed, H. C. M. Vernooy, J. H. M. Verheijden & A. S. J. R. A. M. Van Miert: A liposaccharide-induced acute phase response in pigs is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J. Vet. Pharmacol. Therap. 1996, 19, 382388.
  • Olsen, A. K., K. T. Hansen & C. Friis: Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alfa-ethynylestradiol. Chemical. Biol. Interact. 1997, 107, 93108.
  • Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. J. Biol. Chem. 1964, 239, 23792385.
  • Pearce, R. E., C. J. McIntyre, A. Madan, U. Sanzgire, A. J. Draper, P. L. Bullock, D. C. Cook, L. A. Burton, J. Lathan, C. Nevins & A. Parkinson: Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch. Biochem. Biophys. 1996, 331, 145169.
  • Persson, I., I. Johansson, H. Bergling, M.-L. Dahl, J. Seidegård, R. Rylander, A. Rannug, J. Högberg & M. I. Sundberg: Genetic polymorphism of cytochrome P4502E1 in a Swedish population. FEBS 1977, 319, 207211.
  • Peterson, G. L.: A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 1977, 83, 346356.
  • Rutten, A. A., H. E. Falke, J. F. Catsberg, H. M. Wertelboer, B. J. Blaauboer, L. Doorn, F. X. van Leeuwen, R. Theelen & I. M. Rietjens: Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardisation of assay conditions. Arch. Toxicol. 1992, 66, 237244.
  • Shen, Z., R. L. Wells, J. Liu & M. M. Elkind: Identification of a cytochrome P450 gene by reverse transcription-PCR using degenerate primers containing inosine. Proc. Natl. Acad. 1993, 90, 1148311487.
  • Shimada, T., H. Yamazaki, M. Mimura, Y. Inui & P. Guengerich: Interindividuel variations in human liver cytochrome P-450 enzyme involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with microsomes of 30 Japanese and 30 Caucasians. J. Pharm. Exp. Therap. 1994, 270, 414423.
  • Skaanild, M. T. & C. Friis: Characterization of the P450 system in Göttingen minipigs. Pharmacology & Toxicology 1997, 80 (suppl.), 2833.
  • Thomsen, M. K., C. Friis & P. Nielsen: Purification and characterization of hepatic microsomal cytochrome P-450 in phenobarbital- and ß-naphthoflavone-treated pigs. Pharmacology & Toxicology 1991, 69, 381385.
  • Witkamp, R. F., S. M. Nijmeijer, M. Monshouwer, G. J. M. J. Horbach & A. J. P. A. M. Van Miert: Effect of pre-treatment with cytochrome P450 inducers on hepatic microsomal oxidative biotransformation activities in pigs. 4th European ISSX meeting, Tour, France, 1993 (abstract).